Nishadil
Ads Astrology Calendar Devs Domains Finance Pay Rewards Weather
Signup Signin
Washington | 13°C (overcast clouds)
Topic Feed

NovoNordiskAS

Showing the latest stories and updates for this topic.
Market Navigator: Your Essential Pre-Bell Briefing

Market Navigator: Your Essential Pre-Bell Briefing
Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance

Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance
GLP-1 Drugs: The Unexpected Battle Against Addiction

GLP-1 Drugs: The Unexpected Battle Against Addiction
Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape

Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape
The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market

The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market
A Fresh Look at Pharma Giants: Why Cramer Says J&J, Merck, and Amgen Still Offer Value

A Fresh Look at Pharma Giants: Why Cramer Says J&J, Merck, and Amgen Still Offer Value
Novo Nordisk CEO Projects Strong Supply for Game-Changing Wegovy Pill

Novo Nordisk CEO Projects Strong Supply for Game-Changing Wegovy Pill
The Shifting Sands of US Drug Pricing: Why Big Pharma Investors are on Edge

The Shifting Sands of US Drug Pricing: Why Big Pharma Investors are on Edge
The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback

The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback
Kicking Off the Year: Unpacking the 'Final Trades' for 2026

Kicking Off the Year: Unpacking the 'Final Trades' for 2026
The Last-Minute Playbook: Unpacking 2025's Final Market Calls

The Last-Minute Playbook: Unpacking 2025's Final Market Calls
The Future is Oral: Why Novo Nordisk's Wegovy Pill is a Game-Changer

The Future is Oral: Why Novo Nordisk's Wegovy Pill is a Game-Changer
The Closing Bell: Unpacking Our Final Trades for a Volatile Market

The Closing Bell: Unpacking Our Final Trades for a Volatile Market
The Closing Bell: Navigating Today's Final Trades with BABA, ZM, NVO, and TJX

The Closing Bell: Navigating Today's Final Trades with BABA, ZM, NVO, and TJX
Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look
The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp

The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging

The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging
The Final Verdict: Top Stock Picks Poised for Growth

The Final Verdict: Top Stock Picks Poised for Growth
Load more..